Previous Close | 139.48 |
Open | 139.98 |
Bid | 140.02 x 100 |
Ask | 140.48 x 100 |
Day's Range | 139.40 - 140.80 |
52 Week Range | 74.75 - 142.00 |
Volume | |
Avg. Volume | 3,095,549 |
Market Cap | 54.038B |
Beta (5Y Monthly) | 1.17 |
PE Ratio (TTM) | 107.82 |
EPS (TTM) | 1.30 |
Earnings Date | Apr 25, 2024 - Apr 29, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 149.14 |
Subscribe to Yahoo Finance Plus to view Fair Value for DXCM
Dexcom Stock: The diabetes play rallied to new highs this week, topping a new buy point in the wake of the FDA's clearance of a new device.
Investors are optimistic about DexCom's (DXCM) strong product portfolio.
Brown Capital Management, an investment management company, released its “The Brown Capital Management Mid Company Fund” fourth quarter 2023 investor letter. A copy of the same can be downloaded here. The Mid Company Fund returns of 14.08% in the quarter slightly lagged the 14.55% return for the Russell Midcap Growth Index. The fund declined 27.14% for […]